Algo version: 0.98b
Getein Biotech, Inc is listed at the SHH Exchange
Getein Biotech, Inc [603387.SS]
SHH Sector: Healthcare Industry:Medical Devices

Is Getein Biotech, Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Getein Biotech, Inc pays dividends. Last time was Thursday 19th of September 2024 where the investors holding the stock on Thursday 19th of September 2024 were paid CNY0.09 per share. Over the last 9 times between 2018 and 2024, Getein Biotech, Inc has paid CNY2.6858 with an average of CNY0.3 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Getein Biotech, Inc 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY13.08, you would have made a loss of CNY-4.81 per share or -36.77%

Yes, the average daily trading liquidity for Getein Biotech, Inc is CNY4.60 million. You should therefore be able to get in and out of your positions relatively fast.

Getein Biotech, Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.60, the company's ability to pay off the debt is good. Getein Biotech, Inc has a very good net profit margin of 20.09% and should have very high tolerances against inflation.

We have calculated the inflation risk for Getein Biotech, Inc to be low [0.15 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.